2019 Pediatric RX, Module 2: Immunization Update
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
INTRODUCTION: This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 1.0 is pharmacology content.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2019 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Review of current information from the CDC regarding immunizations.
- Learn the most current information regarding vaccine safety and efficacy.
- Discuss of vaccines in development.
Teri Moser Woo, PhD, RN, CNL, CPNP-PC, FAANP: Professor and Director of Nursing, Saint Martin’s University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
Dr. Moser Woo has no financial relationships with any commercial entities to disclose, and will not discuss off label use and/or investigational use of individual drugs in this presentation.
- 1.00 Contact hours